New Study on Musculoskeletal Diseases and Conditions: Muscular Atrophy

Strategic Insights -

A groundbreaking study from Harbin Medical University Cancer Hospital in China has made a significant breakthrough in the field of muscular atrophy research. The study's primary aim was to evaluate the prognostic efficacy of the alkaline phosphatase to prealbumin ratio (APR) against eight established hematological biomarkers. The research introduced a novel composite biomarker, APR-sarcopenia, which combines hematological indices with computed tomography-quantified body composition parameter. The study's findings suggest that APR-sarcopenia can predict survival probabilities in gastric cancer patients after surgical resection.

Key Takeaways:

  • The study included 190 gastric cancer patients who underwent surgery between January 2016 and December 2017.
  • The patients were divided into three groups based on sarcopenia and APR levels, with Group 3 having longer progression-free survival (PFS) (HR = 0.403).
  • APR-sarcopenia was found to be a significant predictor of survival in gastric cancer patients, outperforming established hematological biomarkers.
  • The study's results suggest that APR-sarcopenia can help identify patients at high risk of metastasis and recurrence following gastric cancer surgery.

Statistics:

  • 190 gastric cancer patients were included in the study.
  • The study reported a hazard ratio (HR) of 0.403 for progression-free survival (PFS) in patients in Group 3.
  • The study used computed tomography (CT) scans to quantify body composition parameters.

Sources:

  • The research was published in Frontiers in Nutrition (2025;12:1636230).
  • The study was conducted by researchers from Harbin Medical University Cancer Hospital, including Zhongze Du, Yunxin Xu, Yingwei Xue, and Hongjiang Song.
  • Frontiers Media Sa, Avenue Du Tribunal Federal 34, Lausanne, Ch-1015, Switzerland publishes Frontiers in Nutrition.